l-DOPA pharmacokinetics in the MPTP-lesioned macaque model of Parkinson's disease

2012/06/18 by Philippe Huot, Tom H. Johnston, James B. Koprich +2 · 2 citations
Medicine · Neuroscience · #Parkinson's Disease Mechanisms and Treatments #Neurotransmitter Receptor Influence on Behavior #Neurological disorders and treatments

paper · doi:10.1016/j.neuropharm.2012.06.012

Cited by

• Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonism
• Effect of the mGlu4 positive allosteric modulator ADX-88178 on parkinsonism, psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset